Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform
Investment will support commercialization of GPX and ULTRA Embolic Devices and development of IMPASS neurovascular platform.
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
Novel gel embolic designed to give physicians greater control and consistency during embolization.
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient.
Fluidx Embolic IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting
First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial
Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses.
Fluidx Unveils New Embolic for Neurovascular Use
New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain
Multi-Center Liquid Embolic Study Concludes
Completion of Trial is a Sign of Things to Come for Novel Embolic Agent
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
Metastatic Tumor Treatment with Novel GPX Embolic Device
Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases
Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage
Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
